Article 15 Jul 2024 FDA Issues Revised Draft Guidance On Addressing Misinformation About Medical Devices And Prescription Drugs United States Healthcare
Article 11 Jul 2024 When APA Claims Accrue Under Corner Post: Implications For The Life Sciences Industry United States Healthcare
Article 03 Jul 2024 Chevron Overturned: What Does It Mean For Life Sciences Companies? United States Healthcare
Article 08 May 2024 Five Key Takeaways From FDA's Updated Draft Guidance On Biosimilars Promotion United States Healthcare
Article 24 Feb 2024 Navigating The Pending BIOSECURE Act: Implications For U.S.-China Biopharmaceutical Collaboration And National Security United States Technology
Article 14 Nov 2023 Addressing CBRN Threats And Promoting Responsible AI In Healthcare: Insights From President Biden's AI Executive Order United States Healthcare
Article 04 Oct 2023 FDA Proposes To Actively Regulate Laboratory-Developed Tests After Years Of Enforcement Discretion United States Healthcare
Article 20 Jul 2023 FDA And FTC Guidance Documents Target Direct-To-Consumer Medical Product Promotion United States Consumer